Jubilant Pharmova Limited (NSE:JUBLPHARMA)

Jubilant Pharmova Balance Sheet

Financials in millions INR. Fiscal year is April - March.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep 30, 2025	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021
Cash & Equivalents	6,232	10,883	9,564	10,139	9,838	5,020
Short-Term Investments	-	-	-	-	53.53	1,875
Cash & Short-Term Investments	6,232	10,883	9,564	10,139	9,892	6,894
Cash Growth	-42.16%	13.79%	-5.67%	2.50%	43.48%	-51.39%
Accounts Receivable	9,610	10,043	10,134	10,508	9,914	8,693
Other Receivables	991	1,433	2,534	1,678	1,497	1,590
Receivables	10,624	11,487	12,676	12,197	11,426	10,294
Inventory	12,284	11,486	13,038	14,215	12,861	11,429
Prepaid Expenses	-	1,050	910	900	833.54	823.74
Other Current Assets	5,449	866	2,573	173	79.99	84.63
Total Current Assets	34,589	35,772	38,761	37,624	35,092	29,525
Property, Plant & Equipment	58,935	51,682	36,871	33,652	27,911	25,752
Long-Term Investments	447	435	422	2,564	2,386	2,541
Goodwill	26,487	25,410	24,639	24,286	22,428	21,300
Other Intangible Assets	11,559	10,967	10,433	9,510	9,263	8,006
Long-Term Deferred Tax Assets	2,436	2,574	2,327	2,275	1,613	1,547
Other Long-Term Assets	756	721	2,029	1,652	1,211	504.39
Total Assets	135,212	127,564	115,485	111,567	99,909	89,181
Accounts Payable	10,008	10,048	8,563	8,213	5,677	5,205
Accrued Expenses	-	3,947	3,293	2,786	3,091	2,846
Short-Term Debt	-	2,190	1,965	2,583	640	200.01
Current Portion of Long-Term Debt	2,799	676	505	414	3,994	-
Current Portion of Leases	576	556	521	534	521.93	501.34
Current Income Taxes Payable	213	184	370	624	345.06	468.11
Current Unearned Revenue	-	1,286	998	719	909.81	544.6
Other Current Liabilities	7,286	2,759	2,675	1,851	737.41	722.98
Total Current Liabilities	20,882	21,646	18,890	17,724	15,916	10,488
Long-Term Debt	23,188	21,503	31,671	31,104	24,642	25,640
Long-Term Leases	2,265	2,385	1,978	2,133	2,122	1,955
Long-Term Unearned Revenue	12,562	11,375	5,438	2,685	72.96	75.71
Pension & Post-Retirement Benefits	-	715	542	482	516.25	532.31
Long-Term Deferred Tax Liabilities	2,142	1,722	2,108	3,062	3,030	2,473
Other Long-Term Liabilities	8,456	5,832	647	459	445.45	602.28
Total Liabilities	69,495	65,178	61,274	57,649	46,745	41,766
Common Stock	158	158	158	159	159.28	159.28
Retained Earnings	-	53,018	45,397	45,368	46,860	43,187
Comprehensive Income & Other	65,757	9,373	8,784	8,466	6,166	4,069
Total Common Equity	65,915	62,549	54,339	53,993	53,186	47,415
Minority Interest	-198	-163	-128	-75	-21.63	0.31
Shareholders' Equity	65,717	62,386	54,211	53,918	53,164	47,415
Total Liabilities & Equity	135,212	127,564	115,485	111,567	99,909	89,181
Total Debt	28,828	27,310	36,640	36,768	31,920	28,296
Net Cash (Debt)	-22,596	-16,427	-27,076	-26,629	-22,028	-21,401
Net Cash Per Share	-142.20	-103.40	-170.44	-167.32	-138.39	-134.37
Filing Date Shares Outstanding	158.5	158.4	158.35	159.07	159.17	159.17
Total Common Shares Outstanding	158.5	158.4	158.35	159.07	159.17	159.17
Working Capital	13,707	14,126	19,871	19,900	19,176	19,037
Book Value Per Share	415.87	394.89	343.16	339.43	334.14	297.88
Tangible Book Value	27,869	26,172	19,267	20,197	21,495	18,109
Tangible Book Value Per Share	175.83	165.23	121.67	126.97	135.04	113.77
Land	-	380	444	440	447.86	436.86
Buildings	-	7,459	8,622	8,498	7,957	7,744
Machinery	-	31,360	32,484	29,213	26,009	21,826
Construction In Progress	-	27,147	12,523	7,733	2,918	2,778

Source: S&P Global Market Intelligence. Standard template. Financial Sources.